Notice of Application to Register Trade Name Products (Notice No. MPI 548)
Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Names:
Fortekor Plus 5mg pimobendan/10mg Benazepril HCl Tablets for Dogs
Fortekor Plus 1.25mg pimobendan/2.5mg benazepril HCl Tablets for Dogs
References: A11170, A11169
Active Ingredients and Concentrations:
Fortekor Plus 5mg pimobendan/10mg Benazepril HCl Tablets for Dogs
Fortekor Plus 1.25mg pimobendan/2.5mg benazepril HCl Tablets for Dogs
Formulation Type: Tablet
General Use Claim:
For treatment of congestive heart failure in dogs.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Craig Cunningham, Novartis New Zealand Limited, 109 Carlton Gore Road, Newmarket, Auckland 1023.
Dated at Wellington this 29th day of September 2015.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).